PH12014500158B1 - Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof - Google Patents

Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Info

Publication number
PH12014500158B1
PH12014500158B1 PH12014500158A PH12014500158A PH12014500158B1 PH 12014500158 B1 PH12014500158 B1 PH 12014500158B1 PH 12014500158 A PH12014500158 A PH 12014500158A PH 12014500158 A PH12014500158 A PH 12014500158A PH 12014500158 B1 PH12014500158 B1 PH 12014500158B1
Authority
PH
Philippines
Prior art keywords
iodophenylamino
dihydroxypropyl
cyclopropane
sulfonamide
difluoro
Prior art date
Application number
PH12014500158A
Other languages
English (en)
Other versions
PH12014500158A1 (en
Inventor
Maderna Andreas
Vernier Jean-Michel
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12014500158(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of PH12014500158B1 publication Critical patent/PH12014500158B1/en
Publication of PH12014500158A1 publication Critical patent/PH12014500158A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PH12014500158A 2009-07-24 2014-01-16 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof PH12014500158A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (en) 2009-07-24 2010-07-10 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Publications (2)

Publication Number Publication Date
PH12014500158B1 true PH12014500158B1 (en) 2015-09-07
PH12014500158A1 PH12014500158A1 (en) 2015-09-07

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014500158A PH12014500158A1 (en) 2009-07-24 2014-01-16 Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof

Country Status (31)

Country Link
US (3) US8513443B2 (deFl)
EP (1) EP2462111B1 (deFl)
JP (1) JP5776115B2 (deFl)
KR (1) KR101763437B1 (deFl)
CN (2) CN102471246B (deFl)
AR (1) AR079183A1 (deFl)
AU (1) AU2010275780B2 (deFl)
BR (1) BR112012001592A2 (deFl)
CA (2) CA2990097A1 (deFl)
CL (1) CL2012000192A1 (deFl)
CO (1) CO6491075A2 (deFl)
CR (1) CR20120044A (deFl)
CU (1) CU24113B1 (deFl)
DO (1) DOP2012000017A (deFl)
EA (1) EA023623B1 (deFl)
EC (1) ECSP12011621A (deFl)
GT (1) GT201200017A (deFl)
HN (1) HN2012000142A (deFl)
IL (1) IL217312A (deFl)
IN (1) IN2012DN00696A (deFl)
MA (1) MA33452B1 (deFl)
MX (2) MX2012001063A (deFl)
MY (1) MY160421A (deFl)
NZ (1) NZ597738A (deFl)
PE (1) PE20120573A1 (deFl)
PH (1) PH12014500158A1 (deFl)
SG (1) SG177535A1 (deFl)
TN (1) TN2012000027A1 (deFl)
TW (1) TWI524890B (deFl)
UY (1) UY32800A (deFl)
WO (1) WO2011009541A1 (deFl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備
AR086553A1 (es) * 2011-05-27 2014-01-08 Bayer Ip Gmbh Sintesis quiral de n-{3,4-difluoro-2-[(2-fluoro-4-yodofenil)amino]-6-metoxifenil}-1-[2,3-dihidroxi-propil]ciclopropano sulfonamidas
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR THE PREPARATION OF SULPHONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1912636T1 (sl) * 2005-07-21 2014-08-29 Ardea Biosciences, Inc. N-(arilamino)-sulfonamidni inhibitorji MEK
US7897624B2 (en) * 2006-04-18 2011-03-01 Ardea Biosciences Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
EP2175885B1 (en) * 2007-07-30 2016-10-12 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
MX2010011314A (es) * 2008-04-14 2010-11-12 Ardea Biosciences Inc Composiciones y metodos de preparacion y uso de las mismas.
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 (r)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺及(s)-n-(3,4-二氟-2-(2-氟-4-碘苯胺基)-6-甲氧基苯基)-1-(2,3-二羥丙基)環丙烷-1-磺醯胺之製備

Also Published As

Publication number Publication date
CA2768788A1 (en) 2011-01-27
JP5776115B2 (ja) 2015-09-09
US20120178946A1 (en) 2012-07-12
CO6491075A2 (es) 2012-07-31
HK1171218A1 (en) 2013-03-22
EA201200175A1 (ru) 2012-12-28
US20150274651A1 (en) 2015-10-01
IN2012DN00696A (deFl) 2015-06-19
KR20120032536A (ko) 2012-04-05
CL2012000192A1 (es) 2012-10-05
AR079183A1 (es) 2012-01-04
GT201200017A (es) 2013-12-19
US8884058B2 (en) 2014-11-11
SG177535A1 (en) 2012-03-29
HN2012000142A (es) 2015-06-08
MY160421A (en) 2017-03-15
CA2768788C (en) 2018-01-09
US20130261320A1 (en) 2013-10-03
EP2462111B1 (en) 2016-03-30
MX344965B (es) 2017-01-12
HK1198364A1 (zh) 2015-04-10
WO2011009541A1 (en) 2011-01-27
KR101763437B1 (ko) 2017-07-31
BR112012001592A2 (pt) 2016-03-08
JP2013500242A (ja) 2013-01-07
PE20120573A1 (es) 2012-05-17
CU24113B1 (es) 2015-08-27
TW201113017A (en) 2011-04-16
CN103848808B (zh) 2016-02-10
EP2462111A1 (en) 2012-06-13
MX2012001063A (es) 2012-03-26
CR20120044A (es) 2012-03-12
AU2010275780B2 (en) 2015-10-22
CU20120014A7 (es) 2012-06-21
US8513443B2 (en) 2013-08-20
AU2010275780A1 (en) 2012-02-02
US9296686B2 (en) 2016-03-29
EA023623B1 (ru) 2016-06-30
TN2012000027A1 (en) 2013-09-19
MA33452B1 (fr) 2012-07-03
PH12014500158A1 (en) 2015-09-07
CN102471246B (zh) 2015-08-26
CN102471246A (zh) 2012-05-23
CA2990097A1 (en) 2011-01-27
CN103848808A (zh) 2014-06-11
IL217312A (en) 2017-02-28
UY32800A (es) 2011-01-31
IL217312A0 (en) 2012-02-29
NZ597738A (en) 2014-03-28
ECSP12011621A (es) 2012-02-29
TWI524890B (zh) 2016-03-11
DOP2012000017A (es) 2012-05-15

Similar Documents

Publication Publication Date Title
MX2013001677A (es) Formulaciones estables de linaclotida.
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
EP2371347A3 (en) Oral care compositions
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
IL222897A0 (en) Compositions, methods and systems for the synthesis and use of imaging agents
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
WO2010118291A3 (en) Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
PH12014500158B1 (en) Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
MX2012011382A (es) Nuevo polimero.
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
MY169266A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
WO2012065028A3 (en) Substituted tetracyclines
UA106762C2 (uk) Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
WO2012159704A8 (en) Stable crystal modifications of dotap chloride
MX2012007097A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
UA91166C2 (en) use of ethyl ether N-[(2-oxoindolylinylydene-3)-2-oxyacetyl]-aminoacetic acid of the general formula as nootropic and anxyolytic agent
HK1224586A1 (en) Neuroactive steroids, compositions, and uses thereof